Literature DB >> 4621714

Treatment of calcinosis circumscripta with probenecid.

C E Dent, T C Stamp.   

Abstract

A 23-year-old woman presented with an 11-year history of peripheral joint pains and stiffness slowly progressing to the development of gross calcinosis circumscripta. She had no definite evidence of systemic scleroderma. She was first treated for one year with frequent intravenous sodium EDTA, which increased urinary calcium and enhanced negative calcium balance but did not lessen her calcinosis. She was then treated with probenecid up to 2 g daily and her calcinosis lessened steadily over three years. Plasma levels of both phosphorus and urate fell during this time.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4621714      PMCID: PMC1789157          DOI: 10.1136/bmj.1.5794.216

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  A NEW ORAL ISOTOPIC TEST OF CALCIUM ABSORPTION.

Authors:  L V AVIOLI; J E MCDONALD; R A SINGER; P H HENNEMAN
Journal:  J Clin Invest       Date:  1965-01       Impact factor: 14.808

2.  Calcinosis cutis: its relationship to scleroderma.

Authors:  S A MULLER; L A BRUNSTING; R K WINKELMANN
Journal:  AMA Arch Derm       Date:  1959-07

3.  Hyperuricemia in hypoparathyroidism.

Authors:  D BRONSKY; A DUBIN; D S KUSHNER; L R PASCALE
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

4.  Influence of benemid on urinary excretion of phosphate in hypoparathyroidism.

Authors:  L R PASCALE; A DUBIN; W S HOFFMAN
Journal:  Metabolism       Date:  1954-09       Impact factor: 8.694

5.  Inhibition by salicylates of various calcifying connective tissue reactions.

Authors:  A Somogyi; I Berczi; H Selye
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-01

6.  Topics in clinical medicine. Clinical synopsis of scleroderma, simulator of other diseases.

Authors:  P A Tumulty
Journal:  Johns Hopkins Med J       Date:  1968-04

7.  Syndrome of sclerodactyly, calcinosis, Raynaud's phenomenon, and telangiectasia.

Authors:  A W Dellipiani; M George
Journal:  Br Med J       Date:  1967-11-11

8.  The effect of probenecid (benemid) on phosphate excretion and other metabolic processes.

Authors:  C L SPURR; R V FORD; J H MOYER
Journal:  Am J Med Sci       Date:  1954-09       Impact factor: 2.378

9.  Evaluation of theoretical renal phosphorus threshold as an index of renal phosphorus handling.

Authors:  T C Stamp; T E Stacey
Journal:  Clin Sci       Date:  1970-10       Impact factor: 6.124

10.  Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

Authors:  M D Francis; R G Russell; H Fleisch
Journal:  Science       Date:  1969-09-19       Impact factor: 47.728

View more
  5 in total

1.  Calcinosis in scleroderma.

Authors:  J N Rosenberg
Journal:  Proc R Soc Med       Date:  1976-04

2.  Extensive soft tissue calcification (calcinosis universalis) in systemic lupus erythematosus.

Authors:  A Weinberger; J G Kaplan; A R Myers
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

3.  CT assessment of calcinosis in a patient with dermatomyositis.

Authors:  B Fishel; S Diamant; I Papo; M Yaron
Journal:  Clin Rheumatol       Date:  1986-06       Impact factor: 2.980

4.  Extensive calcinosis with minimal scleroderma: treatment of ectopic calcification with aluminum hydroxide.

Authors:  P M Hudson; P E Jones; T W Robinson; C E Dent
Journal:  Proc R Soc Med       Date:  1974-11

5.  Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations.

Authors:  Vishalakshi Viswanath; Meghana M Phiske; Vinay V Gopalani
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.